NCT00123266View on ClinicalTrials.gov

Intra-arterial Microplasmin Administration in Patients With Acute Intracranial Vertebrobasilar Artery Occlusion

PHASE2TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

August 31, 2008

Conditions
Stroke
Interventions
DRUG

Microplasmin

2 mg/kg, IA over 75 mins

Trial Locations (7)

24105

UKSH Campus Kiel, Kiel

65199

HSK Dr. Horst Schmidt Hospital, Wiesbaden

66421

Universitätsklinikum des Saarlandes, Homburg/Saar

D-91054

Universitätsklinikum Erlangen, Erlangen

D-79106

Universitatsklinikum Freiburg, Freiburg im Breisgau

Unknown

Ludwig-Maximilians-University Hospital, Munich

3430 EM

Sint Antonius Ziekenhuis, Nieuwegein

Sponsors

Lead Sponsor

ThromboGenics
All Listed Sponsors
lead

ThromboGenics

INDUSTRY

NCT00123266 - Intra-arterial Microplasmin Administration in Patients With Acute Intracranial Vertebrobasilar Artery Occlusion | Biotech Hunter | Biotech Hunter